C.E. van den Brink

2.3k citations

27 papers · 1.9k · h-index 24

Impact in

Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress
Genetics top 5%
- Estrogen and related hormone effects

Papers in

Molecular Biology 25
- Retinoids in leukemia and cellular processes 13
- Pluripotent Stem Cells Research 5
- CRISPR and Genetic Engineering 2
- RNA Interference and Gene Delivery 2
Genetics 16
- Estrogen and related hormone effects 15

Co-authors: Paul T. van der Saag (24 shared papers)Bart van der Burg (7 shared papers)Christine L. Mummery (7 shared papers)Siegfried W. de Laat (7 shared papers)Gert E. Folkers (3 shared papers)Juliette Legler (1 shared paper)A. Dick Vethaak (1 shared paper)Albertinka J. Murk (1 shared paper)
Journals: Developmental Biology (5 papers)Endocrinology (2 papers)Experimental Cell Research (2 papers)Molecular and Cellular Endocrinology (2 papers)Differentiation (1 paper)
Partner nations: Netherlands France United Kingdom

In The Last Decade

C.E. van den Brink

27 papers receiving 1.9k citations

Peers

Countries citing papers authored by C.E. van den Brink

Since Specialization

Citations

This map shows the geographic impact of C.E. van den Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.E. van den Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.E. van den Brink more than expected).

Fields of papers citing papers by C.E. van den Brink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.E. van den Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.E. van den Brink. The network helps show where C.E. van den Brink may publish in the future.

Co-authors

The 25 scholars most cited alongside C.E. van den Brink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C.E. van den Brink Line = papers co-authored together C.E. van den Brink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line Toxicological Sciences ·Juliette Legler, C.E. van den Brink, Abraham Brouwer, Albertinka J. Murk, Paul T. van der Saag, A. Dick Vethaak, Bart van der Burg	1999	357
2	The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification Nature ·W.W.M. Pim Pijnappel, H. Hendriks, Gert E. Folkers, C.E. van den Brink, Erik-Jan Dekker, C. Edelenbosch, Paul T. van der Saag, Antony J. Durston	1993	228
3	Cardiomyocyte differentiation of mouse and human embryonic stem cells* Journal of Anatomy ·Christine L. Mummery, Dorien Ward, C.E. van den Brink, Stephen D. Bird, Pieter A. Doevendans, Tobias Opthof, Aart Brutel de la Rivière, Leon G.J. Tertoolen, Marcel A. G. van der Heyden, Martín F. Pera	2002	220
4	Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. PubMed ·Edwin Sonneveld, C.E. van den Brink, B.-J. M. Van Der Leede, R.-K. A. M. Schulkes, Martin Petkovich, Bart van der Burg, Paul T. van der Saag	1998	127
5	Clonal variants of differentiated P19 embryonal carcinoma cells exhibit epidermal growth factor receptor kinase activity Developmental Biology ·Christine L. Mummery, A. Feijen, Paul T. van der Saag, C.E. van den Brink, Siegfried W. de Laat	1985	93
6	Ataxia with loss of Purkinje cells in a mouse model for Refsum disease Proceedings of the National Academy of Sciences ·Sacha Ferdinandusse, Anna W.M. Zomer, J.C. Komen, C.E. van den Brink, Melissa Thanos, Frank P.T. Hamers, Ronald J. A. Wanders, Paul T. van der Saag, Bwee Tien Poll‐The, Pedro Brites	2008	85
7	Establishment of a differentiated mesodermal line from P19 EC cells expressing functional PDGF and EGF receptors Experimental Cell Research ·Christine L. Mummery, A. Feijen, Wouter H. Moolenaar, C.E. van den Brink, Siegfried W. de Laat	1986	79
8	Autoinduction of Retinoic Acid Metabolism to Polar Derivatives with Decreased Biological Activity in Retinoic Acid-sensitive, but Not in Retinoic Acid-resistant Human Breast Cancer Cells Journal of Biological Chemistry ·Bas‐jan M. van der Leede, C.E. van den Brink, W.W.M. Pim Pijnappel, Edwin Sonneveld, Paul T. van der Saag, Bart van der Burg	1997	71
9	4-Hydroxytamoxifen Trans-Represses Nuclear Factor-κB Activity in Human Osteoblastic U2-OS Cells through Estrogen Receptor (ER)α, and Not through ERβ* Endocrinology ·Monique E. Quaedackers, C.E. van den Brink, Sacha Wissink, Richard Schreurs, Jan-Ακε Gustafsson, Paul T. van der Saag, Bart van der Burg	2001	69
10	Commitment to differentiation induced by retinoic acid in P19 embryonal carcinoma cells is cell cycle dependent Developmental Biology ·Christine L. Mummery, C.E. van den Brink, Siegfried W. de Laat	1987	62
11	Retinoic acid receptor α1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells Molecular and Cellular Endocrinology ·Bas‐jan M. van der Leede, Gert E. Folkers, C.E. van den Brink, Paul T. van der Saag, Bart van der Burg	1995	57
12	A cyclic AMP response element is involved in retinoic acid-dependent RARβ2 promoter activation Nucleic Acids Research ·Frank A.E. Kruyt, Gert E. Folkers, C.E. van den Brink, Paul T. van der Saag	1992	49
13	Transcriptional regulation of retinoic acid receptor β in retinoic acid-sensitive and -resistant P19 embryocarcinoma cells Mechanisms of Development ·Frank A.E. Kruyt, C.E. van den Brink, Libert H.K. Defize, Marie-Jose Donath, Philippe Kastner, W. Kruijer, Pierre Chambon, Paul T. van der Saag	1991	48
14	Retinoic Acid Hydroxylase (CYP26) Is a Key Enzyme in Neuronal Differentiation of Embryonal Carcinoma Cells Developmental Biology ·Edwin Sonneveld, C.E. van den Brink, Leon G.J. Tertoolen, Bart van der Burg, Paul T. van der Saag	1999	45
15	A short‐term screening test for teratogens using differentiating neuroblastoma cells in vitro Teratology ·Christine L. Mummery, C.E. van den Brink, Paul T. van der Saag, Siegfried W. de Laat	1984	45
16	Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RARα Differentiation ·Frank A.E. Kruyt, Linda J. van der Veer, Silvie Mader, C.E. van den Brink, A. Feijen, Luigi J.C. Jonk, W. Kruijer, Paul T. van der Saag	1992	40
17	Retinoic acid receptor and retinoid X receptor expression in retinoic acid—resistant human tumor cell lines Molecular Carcinogenesis ·Bas‐jan M. van der Leede, C.E. van den Brink, Paul T. van der Saag	1993	40
18	Cell scattering of SK-N-MC neuroepithelioma cells in response to Ret and FGF receptor tyrosine kinase activation is correlated with sustained ERK2 activation Oncogene ·André AFL van Puijenbroek, D H van Weering, C.E. van den Brink, Johannes L. Bos, Paul T. van der Saag, Siegfried W. de Laat, Jeroen den Hertog	1997	35
19	Direct interaction between estrogen receptor α and NF-κB in the nucleus of living cells Molecular and Cellular Endocrinology ·Monique E. Quaedackers, C.E. van den Brink, Paul T. van der Saag, Leon G.J. Tertoolen	2007	35
20	The cell cycle, cell death, and cell morphology during retinoic acid-induced differentiation of embryonal carcinoma cells Developmental Biology ·Christine L. Mummery, C.E. van den Brink, Paul T. van der Saag, Siegfried W. de Laat	1984	32

About C.E. van den Brink

C.E. van den Brink is a scholar working on Molecular Biology, Genetics, Biochemistry, Cancer Research and Cellular and Molecular Neuroscience, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (15 papers), Retinoids in leukemia and cellular processes (13 papers), Pluripotent Stem Cells Research (5 papers), Antioxidant Activity and Oxidative Stress (4 papers), CRISPR and Genetic Engineering (2 papers), Nuclear Receptors and Signaling (2 papers), Reproductive System and Pregnancy (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Biochemistry (234 citations), Genetics (703 citations), Health, Toxicology and Mutagenesis (304 citations), Molecular Biology (1.4k citations) and Physiology (67 citations). C.E. van den Brink has collaborated with scholars based in Netherlands, France and United Kingdom. Frequent co-authors include Paul T. van der Saag, Bart van der Burg, Christine L. Mummery, Siegfried W. de Laat, Gert E. Folkers, Juliette Legler, A. Dick Vethaak, Albertinka J. Murk, Abraham Brouwer and Edwin Sonneveld. Their work appears in journals such as Developmental Biology, Endocrinology, Experimental Cell Research, Molecular and Cellular Endocrinology and Differentiation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

C.E. van den Brink

Impact in

Papers in i

In The Last Decade

C.E. van den Brink

Peers

Countries citing papers authored by C.E. van den Brink

Fields of papers citing papers by C.E. van den Brink

All Works

About C.E. van den Brink

Explore authors with similar magnitude of impact

Papers in